Evidence map›Paper›PMID 34996123›Full record

ArticleJournal of orthopaedic research : official publication of the Orthopaedic Research Society2022

Osteochondroma formation is independent of heparanase expression as revealed in a mouse model of hereditary multiple exostoses.

Christina Mundy, Juliet Chung, Eiki Koyama, Stuart Bunting, Rajeev Mahimkar, Maurizio Pacifici

Open access · greenAbstract read
In one paragraph

Article in Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. The Pathophysiological Functions of Heparanases: From Evolution, Structural and Tissue-Specific Perspectives.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Christina MundyTranslational Research Program in Pediatric Orthopaedics, Division of Orthopaedic Surgery, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Juliet ChungTranslational Research Program in Pediatric Orthopaedics, Division of Orthopaedic Surgery, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Eiki KoyamaTranslational Research Program in Pediatric Orthopaedics, Division of Orthopaedic Surgery, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Stuart BuntingBioMarin Pharmaceutical, Inc., Novato, California, USA.
Rajeev MahimkarBioMarin Pharmaceutical, Inc., Novato, California, USA.
Maurizio PacificiTranslational Research Program in Pediatric Orthopaedics, Division of Orthopaedic Surgery, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.ORCID 0000-0001-6854-4942
Children's Hospital of Philadelphia · USBioMarin (United States) · US

Funding

Pathogenic Mechanisms in Hereditary Multiple Exostoses SyndromeR01AR061758 · NIAMS · CHILDREN'S HOSP OF PHILADELPHIA · PI Maurizio Pacifici · 2011 to 2026
$6.3M
NIAMS NIH HHS R01 AR061758
6 · The paper itself

Abstract

Hereditary multiple exostoses (HME) is a rare, pediatric disorder characterized by osteochondromas that form along growth plates and provoke significant musculoskeletal problems. HME is caused by mutations in heparan sulfate (HS)-synthesizing enzymes EXT1 or EXT2. Seemingly paradoxically, osteochondromas were found to contain excessive extracellular heparanase (Hpse) that could further reduce HS levels and exacerbate pathogenesis. To test Hpse roles, we asked whether its ablation would protect against osteochondroma formation in a conditional HME model consisting of mice bearing floxed Ext1 alleles in Agr-CreER background (Ext1

Indexed as

Bone NeoplasmsExostoses, Multiple HereditaryGlucuronidaseN-AcetylglucosaminyltransferasesOsteochondromaAnimalsChildDisease Models, AnimalExostosin 1HeparanaseHeparan SulfateHumansMiceMutationRetinoidsTamoxifenExostosin 1GlucuronidaseHeparanaseHeparan SulfateN-AcetylglucosaminyltransferasesRetinoidsTamoxifenheparanasehereditary multiple exostosesPalovarotene

Identifiers

PMID34996123
PMCPMC9259764
OpenAlexW4206350330

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.